Pharmacological stress thallium scintigraphy with 2- cyclohexylmethylidenehydrazinoadenosine (WRC-0470): A novel, short-acting adenosine A(2A) receptor agonist

Circulation

Volumn 94, Issue 7, 1996, Pages 1726-1732

  Glover, David K ^a,c   Ruiz, Mirta ^a   Yang, Joo Y ^a   Koplan, Bruce A ^a   Allen, Terry R ^a   Smith, William H ^a   Watson, Denny D ^a   Barrett, Richard J ^b   Beller, George A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b ADERIS Pharmaceuticals Inc   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

adenosine; imaging; radioisotopes; receptors

Indexed keywords

2 CYCLOHEXYLMETHYLIDENEHYDRAZINOADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; BINODENOSON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DOG; DRUG STRUCTURE; EXERCISE TEST; HEART LEFT VENTRICLE DP-DT; HEMODYNAMICS; HYPOTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SCINTIANGIOGRAPHY;

EID: 0029778320     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.7.1726     Document Type: Article

References (27)

1. 201Tl single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction. Circulation. 1993;87:1197-1210.
2. Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial. J Am Coll Cardiol. 1992;20:265-275.
3. Coyne EP, Belvedere DA, Vande Streck PR, Weiland FL, Evans KB, Spaccavento LJ. Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease. J Am Coll Cardiol. 1991;17:1289-1294.
4. Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. J Am Coll Cardiol. 1992;19:248-257.
5. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol. 1994;23:384-390.
6. 2 adenosine receptors in the aorta and the coronary vessels from the guinea pig. J Pharmcol Exp Ther. 1993;265:248-253.
7. Nagashima S, Moore HJ, Tracy CM, Solomon AJ, Hewett-Maulman JL, Cowley SM, Woosley RL, Barbey JT. Dose ranging study of N-0861, a new selective A, adenosine receptor antagonist, in patients receiving adenosine. J Am Coll Cardiol. 1994;23:478A. Abstract.
8. 6-endonorbomran-2-yl-9-methyladenine, in humans. Drug Dev Res. 1994;31:278. Abstract.
9. Gaspardone A, Crea F, Iamele M, Tomai F, Versaci F, Pellegrino A, Chiariello L, Gioffre PA. Bamiphylline improves exercise-induced myocardial ischemia through a novel mechanism of action. Circulation. 1993;88:502-508.
10. Gaspardone A, Crea F, Tomai F, Versaci F, Iamele M, Gioffre G, Chiariello L, Gioffre PA. Muscular and cardiac adenosine-induced pain is mediated by Al receptors. J Am Coll Cardiol. 1995;25:251-270.
11. Glover DK, Ruiz M, Sansoy V, Barrett RJ, Beller GA. Effect of N-0861, a selective adenosine A1 receptor antagonist, on pharmacologic stress imaging with adenosine. J Nucl Med. 1995;36:270-275.
12. 2 adenosine receptor J Med Chem. 1991;34:1334-1339.
13. 2 receptor agonist. Cardiovasc Drug Rev. 1992;1:26-53.
14. Niiya K, Olsson RA, Thompson RD, Silvia SK, Ueeda M. 2-(N′-Alkylidenehydrazino) adenosines: potent and selective coronary vasodilators. J Med Chem. 1992;35:4557-4561.
15. 2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands. J Pharmacol Exp Ther. 1991;259:1203-1212.
16. Glover DK, Ruiz M, Simanis JP, Smith WH, Watson DD, Beller GA. Comparison between thallium-201 and Tc-99m sestamibi uptake during adenosine hyperemia in a canine model of either mild or severe coronary stenoses. Circulation. 1995;91:813-820.
17. 6-endonorbornan-2-yl-9-methyladenine, N-0861, on the negative chronotropic and vasodilatory actions of adenosine in the canine heart in vivo. Can J Physiol Pharmacol. 1992;70:1450-1456.
18. Heymann MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurement with radionuclide-labeled particles. Prog Cardiovasc Dis. 1987;20:55-79.
19. Fozard JR, Hannon JP. BW-A522 blocks adenosine A3 receptor-mediated hypotensive responses in the rat. Eur J Pharmacol. 1994;252:R5-R6.
20. Hannon JP, Pfannkuche HJ, Fozard JR. A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br J Pharmacol. 1995;115:945-952.
21. 2B receptors in the guinea pig aorta. Eur J Pharmacol. 1992;216:235-242.
22. Glover DK, Okada RD. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Circulation. 1990;81:628-636.
23. Granato JE, Watson DD, Belardinelli L, Cannon JM, Beller GA. Effects of dipyridamole and aminophylline on hemodynamics, regional myocardial blood flow and thallium-201 washout in the setting of a critical coronary stenosis. J Am Coll Cardiol. 1990;16: 1760-1770.
24. Abreu A, Mahmarian JJ, Nishimura S, Boyce TM, Verani MS. Tolerance and safety of pharmacologic coronary vasodilatation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol. 1991;18:730-735.
25. O'Keefe JH Jr, Bateman TM, Silvestri R, Barnhart C. Safety and diagnostic accuracy of adenosine thallium-201 scintigraphy in patients unable to exercise and those with left bundle branch block. Am Heart. 1992;124:614-621.
26. Lette J, Tatum JL, Fraser S, Miller DD, Waters DD, Heller G, Stanton EB, Bom HS, Leppo J, Nattel S. Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol. 1995;2:3-17.
27. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem. 1993;268:16887-16890.